A detailed history of Bank Of America Corp transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Bank Of America Corp holds 2,825 shares of CLGN stock, worth $11,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,825
Previous 7,300 61.3%
Holding current value
$11,695
Previous $36,000 61.11%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.28 - $5.45 $19,153 - $24,388
-4,475 Reduced 61.3%
2,825 $14,000
Q4 2023

Feb 14, 2024

SELL
$4.97 - $6.64 $442 - $590
-89 Reduced 1.2%
7,300 $46,000
Q1 2023

May 12, 2023

BUY
$6.74 - $12.99 $17,449 - $33,631
2,589 Added 53.94%
7,389 $51,000
Q3 2022

Nov 14, 2022

BUY
$6.3 - $9.99 $30,240 - $47,952
4,800 New
4,800 $33,000

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $45.9M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.